Fingerprint
Dive into the research topics of 'Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically